Development of a cancer DNA phenotype prior to tumor formation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 101, Issue 29, 2004, Pages 10721-10725

  Malins, Donald C ^a   Anderson, Katie M ^a   Gilman, Naomi K ^a   Green, Virginia M ^a   Barker, Edward A ^b   Hellström, Karl Erik ^a  

^a PACIFIC NORTHWEST RESEARCH INSTITUTE   (United States)

^b Molecular Oncology International   (United States)

Author keywords

3 methylcholanthrene; Antineoplastic agents; Cancer inhibition; Cancer prediction; Cyclophosphamide

Indexed keywords

3 METHYLCHOLANTHRENE; ANTINEOPLASTIC AGENT; CANCER DNA; CARCINOGEN; CYCLOPHOSPHAMIDE; DEOXYRIBOSE; DNA; DNA BASE; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER; CANCER INHIBITION; CARCINOGENESIS; CONTROLLED STUDY; DNA STRUCTURE; DRUG EFFECT; FEMALE; INFRARED SPECTROSCOPY; MOUSE; NONHUMAN; PHENOTYPE; PREDICTION; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CYCLOPHOSPHAMIDE; DNA; FEMALE; METHYLCHOLANTHRENE; MICE; MICE, INBRED BALB C; MUSCLE, SKELETAL; NEOPLASMS; PHENOTYPE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

ANIMALIA;

EID: 3242697646     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0403888101     Document Type: Article

References (31)

1. Quattrochi, L. C., Vu, T. & Tukey, R. H. (1994) J. Biol. Chem. 269, 6949-6954.
2. Atlas, S. A., Taylor, B. A., Diwan, B. A. & Nebert, D. W. (1976) Genetics 83, 537-550.
3. Shimokado, K., Watanabe, H., Sumii, M., Miyagawa, K., Kamiya, K., Dohi, K. & Niwa, O. (1998) Jpn. J. Cancer Res. (GANN) 89, 269-277.
4. Flesher, J. W., Horn, J. & Lehner, A. F. (1998) Biochem. Biophys. Res. Commun. 243, 30-35.
5. King, H. W. S., Osborne, M. R. & Brookes, P. (1977) Int. J. Cancer 20, 564-571.
6. Boddy, A. V. & Yule, S. M. (2000) Clin. Pharmacokinet. 38, 291-304.
7. Hellström, I. & Hellström, K. E. (1978) Nature 275, 129-130.
8. Baumann, F. & Preiss, R. (2001) J. Chromatogr. B Biomed. Sci. Appl. 764, 173-192.
9. Kohn, K. W., Hartley, J. A. & Mattes, W. B. (1987) Nucleic Acids Res. 15, 10531-10549.
10. Springer, J. B., Colvin, M. E., Colvin, O. M. & Ludeman, S. M. (1998) J. Org. Chem. 63, 7218-7222.
11. Chung, F. L., Young, R. & Hecht, S. S. (1984) Cancer Res. 44, 990-995.
12. Smith, R. A., Williamson, D. S. & Cohen, S. M. (1989) Chem. Res. Toxicol. 2, 267-271.
13. Smith, R. A., Williamson, D. S., Cerny, R. L. & Cohen, S. M. (1990) Cancer Res. 50, 3005-3012.
14. Sodum, R. S. & Shapiro, R. (1988) Bioorg. Chem. 16, 272-282.
15. O'Connor, P. M., Wassermann, K., Sarang, M., Magrath, I., Bohr, V. A. & Kohn, K. W. (1991) Cancer Res. 51, 6550-6557.
16. Hickman, J. A. (1992) Cancer Metastasis Rev. 11, 121-139.
17. Malins, D. C., Anderson, K. M., Polissar, N. L., Ostrander, G. K., Knobbe, E. T., Green, V. M., Gilman, N. K. & Spivak, J. L. (2004) Proc. Natl. Acad. Sci. USA 101, 5008-5011.
18. Malins, D. C., Johnson, P. M., Barker, E. A., Polissar, N. L., Wheeler, T. M. & Anderson, K. M. (2003) Proc. Natl. Acad. Sci. USA 100, 5401-5406.
19. Garcia-Closas, M., Hankinson, S. E., Ho, S., Malins, D. C., Polissar, N. L., Schaefer, S. N., Su, Y. & Vinson, M. A. (2000) J. Natl. Cancer Inst. 27, 147-156.
20. Malins, D. C., Polissar, N. L., Ostrander, G. K. & Vinson, M. A. (2000) Proc. Natl. Acad. Sci. USA 97, 12442-12445.
21. Malins, D. C., Polissar, N. L., Schaefer, S., Su, Y. & Vinson, M. (1998) Proc. Natl. Acad. Sci. USA 95, 7637-7642.
22. Malins, D. C., Polissar, N. L., Nishikida, K., Holmes, E. H., Gardner, H. S. & Gunselman, S. J. (1995) Cancer (Philadelphia) 75, 503-517.
23. Malins, D. C., Polissar, N. L., Su, Y., Gardner, H. S. & Gunselman, S. J. (1997) Nat. Med. 3, 927-930.
24. Malins, D. C., Polissar, N. L. & Gunselman, S. J. (1997) Proc. Natl. Acad. Sci. USA 94, 259-264.
25. Malins, D. C., Polissar, N. L. & Gunselman, S. J. (1996) Proc. Natl. Acad. Sci. USA 93, 14047-14052.
26. Tsuboi, M. (1969) Appl. Spectrosc. Rev. 3, 45-90.
27. Turner, B. M. (2001) Chromatin and Gene Regulation: Mechanisms in Epigenetics (Blackwell, Oxford), pp. 25-41.
28. Loeb, L. A. (1991) Cancer Res. 51, 3075-3079.
29. Loeb, L. A. & Christians, F. C. (1996) Mutat. Res. 350, 279-286.
30. Fleming, R. A. (1997) Pharmacotherapy 17, S146-S154.
31. Schwartz, P. S. & Waxman, D. J. (2001) Mol. Pharmacol. 60, 1268-1279.